Welcome to the ValueWiki Antisoma Plc (ASM:LSE) article! Register for free or click the "edit" link to contribute!

Antisoma Plc (ASM:LSE)

This summary section needs content! Click Here to begin writing.

Have a question about Antisoma Plc? Ask it on the Message Board or Chat Room

Visit the Apple, Inc. page for an example of a complete article.

Today

Max

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

11/26/08 11:11 am	Antisoma to present at Piper Jaffray Conference (Marketwire)
11/18/08 2:11 am	Antisoma AGM update and Interim Management Statement (Marketwire)
11/13/08 7:11 am	Antisoma to present at Lazard Capital Markets 5th Annual Healthcare Conference in New York (Marketwire)
11/06/08 7:11 am	Antisoma to present at Rodman & Renshaw 10th Annual Healthcare Conference in New York (Marketwire)
10/28/08 8:10 am	Antisoma appoints Eric Dodd as Chief Financial Officer (Marketwire)
10/07/08 1:10 am	Antisoma and The Institute of Cancer Research to collaborate on novel approach to cancer treatment (Marketwire)
09/30/08 1:09 am	Antisoma starts phase II trial of AS1402 in breast cancer (Marketwire)
09/18/08 1:09 am	Antisoma's preliminary results for the year ended 30 June 2008 (Marketwire)
09/16/08 8:09 am	Antisoma to present at Merrill Lynch and UBS Global Pharmaceutical Conferences (Marketwire)
09/04/08 1:09 am	Antisoma starts phase II trial of AS1411 in renal cancer (Marketwire)